ArticleCancers2021

Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy.

Ugo Giovanni Falagario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.